CAJ | 학술논문

新生血管性青光眼( neovascular glaucoma,NVG)是一种病因复杂、破坏性极强、治疗效果较差的难治性眼病。广泛的视网膜缺血缺氧是其主要病因,早期诊断、积极预防、采取有效措施抑制新生血管生成是其治疗的关键。根据近年来国内外相关文献对NVG治疗的报导,我们对NVG药物、手术、联合治疗的新进展、新思路加以综述。
신생혈관성청광안( neovascular glaucoma,NVG)시일충병인복잡、파배성겁강、치료효과교차적난치성안병。엄범적시망막결혈결양시기주요병인,조기진단、적겁예방、채취유효조시억제신생혈관생성시기치료적관건。근거근년래국내외상관문헌대NVG치료적보도,아문대NVG약물、수술、연합치료적신진전、신사로가이종술。
Neovascular glaucoma ( NVG ) is a kind of intractable eye disease with complex etiology, strong destruction and poor effect on treatment. Extensive retinal ischemia and hypoxia is the main etiology, and the key of treatment is early diagnosis, active prevention and taking effective measures to prevent the production of vascular endothelial growth factor. According to the related literature over recent years, the authors will discuss pros and cons for medical, surgical and combined treatment in this review.